Hepatitis C infection in HIV-1 natural viral suppressors.
about
Statistical linkage analysis of substitutions in patient-derived sequences of genotype 1a hepatitis C virus nonstructural protein 3 exposes targets for immunogen designA low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers.Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers.Altered T-cell subsets in HIV-1 natural viral suppressors (elite controllers) with hepatitis C infection.IL28B genotype does not correlate with HIV control in African Americans.HIV/HCV-coinfected natural viral suppressors have better virologic responses to PEG-IFN and ribavirin than ARV-treated HIV/HCV patients.HIV/hepatitis C coinfection natural history and disease progression.Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors.Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressorsHepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study.Challenges for HCV vaccine development in HIV-HCV coinfection.Gene-disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections.Long-term follow-up of elite controllers: Higher risk of complications with HCV coinfection, no association with HIV disease progression.HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term.Repeated spontaneous clearance of hepatitis C virus infection in the setting of long-term non-progression of HIV infection.Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African-American elite controllers/suppressors.Hepatitis C virus replication in Caucasian HIV controllers.
P2860
Q30361685-10348797-638B-41A8-9B33-8F9A7A67937BQ33815728-46C6EABC-3D4B-47CD-AF52-938FE700F3CAQ34015054-999F64CE-074A-482D-A1B9-A2C00EF0CDD9Q34611671-CC87C472-1E85-459B-97BE-6A2C4A851D18Q35205904-2CCBDFC7-9A84-4FD0-92F2-AE39DE37DD20Q35218240-6E25C28C-B593-4764-98DA-942F8FC87B29Q35801431-F21D152E-936B-4890-BE08-C4010EA9B057Q36010933-470C622D-C4A8-4355-AFA3-D22FCCA26BA6Q37169522-C2BEB038-3CAD-4425-9F49-1DAD2A3B6C4BQ37726687-DB145E6B-315C-4114-901D-A7EC37C8F60BQ38036684-EF05E883-36F6-491E-8205-080A00ECFC7DQ38859455-B3854DA4-C3FF-4A45-9DA6-5A285F6A4DF8Q40142539-5751128B-3479-410F-ACCB-E47D52F26CAEQ41762711-5157D547-B455-4706-869D-7DB12EF39A70Q42700146-9445C0A0-B22B-4450-B473-0F5CFEBF1D7DQ42871992-4F24F509-43B4-4122-B6CF-387672221A4FQ43037903-524694E3-553F-4679-9702-CEAFA763F208
P2860
Hepatitis C infection in HIV-1 natural viral suppressors.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hepatitis C infection in HIV-1 natural viral suppressors.
@ast
Hepatitis C infection in HIV-1 natural viral suppressors.
@en
type
label
Hepatitis C infection in HIV-1 natural viral suppressors.
@ast
Hepatitis C infection in HIV-1 natural viral suppressors.
@en
prefLabel
Hepatitis C infection in HIV-1 natural viral suppressors.
@ast
Hepatitis C infection in HIV-1 natural viral suppressors.
@en
P2093
P2860
P1433
P1476
Hepatitis C infection in HIV-1 natural viral suppressors
@en
P2093
Mohammad M Sajadi
Robert R Redfield
Rohit Talwani
P2860
P304
P356
10.1097/QAD.0B013E32833A2A32
P407
P577
2010-07-01T00:00:00Z